SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-006231
Filing Date
2022-03-08
Accepted
2022-03-08 06:07:42
Documents
91
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm   iXBRL 10-K 2415810
2 ex4-6.htm EX-4.6 39501
3 ex10-15.htm EX-10.15 91207
4 ex10-16.htm EX-10.16 102615
5 ex21-1.htm EX-21.1 4808
6 ex23-1.htm EX-23.1 3997
7 ex31-1.htm EX-31.1 11090
8 ex31-2.htm EX-31.2 11440
9 ex32-1.htm EX-32.1 10455
10 form10k_002.jpg GRAPHIC 10934
11 form10k_003.jpg GRAPHIC 33594
12 form10k_005.jpg GRAPHIC 39691
13 form10k_006.jpg GRAPHIC 19214
14 form10k_008.jpg GRAPHIC 79341
15 form10k_009.jpg GRAPHIC 37501
  Complete submission text file 0001493152-22-006231.txt   9624176

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE mtnb-20211231.xsd EX-101.SCH 53435
17 XBRL CALCULATION FILE mtnb-20211231_cal.xml EX-101.CAL 65995
18 XBRL DEFINITION FILE mtnb-20211231_def.xml EX-101.DEF 190824
19 XBRL LABEL FILE mtnb-20211231_lab.xml EX-101.LAB 463112
20 XBRL PRESENTATION FILE mtnb-20211231_pre.xml EX-101.PRE 354506
85 EXTRACTED XBRL INSTANCE DOCUMENT form10k_htm.xml XML 1435761
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38022 | Film No.: 22720243
SIC: 2834 Pharmaceutical Preparations